Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Dimitris Karanassos"'
Autor:
Despo Ierodiakonou, Maria Kampouraki, Ioannis Poulonirakis, Polyvios Papadokostakis, Eleftheria Lintovoi, Dimitris Karanassos, Kyriakos Maltezis, Maria Chorti, Evangelos Petrovitsos, Sofia Dimopoulou, Sam Hamind, Ioannis Gialamas, Polyxeni Athanasiou, Vasiliki Bempi, Irene Lambraki, Ioanna Tsiligianni
Publikováno v:
BMC Pulmonary Medicine, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Frailty is a state of increased vulnerability that has a significant risk of unfavorable outcomes such as increased dependency and/or death, but little is known about frailty in people with chronic obstructive pulmonary disease (C
Externí odkaz:
https://doaj.org/article/0dfa76988e884bcebff6c7acf149dae7
Autor:
David Lorenz, Manuel Brütsch, Lukas Hegetschweiler, Charalampos S. Kouzinopoulos, Marcel Meli, Stefan Stajic, Dimitris Karanassos, Manuel Bobel
Publikováno v:
IDAACS-SWS
© 2020 IEEE. Personal use of this material is permitted. Permission from IEEE must be obtained for all other uses, in any current or future media, including reprinting/republishing this material for advertising or promotional purposes, creating new
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3f8689346c6d670a7d6fc40473824ed
https://zenodo.org/record/5926015
https://zenodo.org/record/5926015
Autor:
Maria Chorti, Ioannis Poulonirakis, Irene Lambraki, Polyvios Papadokostakis, Despo Ierodiakonou, Vasiliki Bempi, Maria Kampouraki, Sofia Dimopoulou, Sam Hamind, Kyriakos Maltezis, Dimitris Karanassos, Ioannis Gialamas, Polyxeni Athanasiou, Evangelos Petrovitsos, Eleftheria Lintovoi, Ioanna Tsiligianni
Publikováno v:
BMC Pulmonary Medicine
BMC Pulmonary Medicine, Vol 19, Iss 1, Pp 1-9 (2019)
BMC Pulmonary Medicine, Vol 19, Iss 1, Pp 1-9 (2019)
Background Frailty is a state of increased vulnerability that has a significant risk of unfavorable outcomes such as increased dependency and/or death, but little is known about frailty in people with chronic obstructive pulmonary disease (COPD). Met